Literature DB >> 3323405

Immune reactivity in the nervous system: modulation of T-lymphocyte activation by glial cells.

H Wekerle1, D Sun, R L Oropeza-Wekerle, R Meyermann.   

Abstract

The vertebrate central nervous system (CNS) has been traditionally thought to be inaccessible for the passenger lymphocytes of the immune system. This does not seem to be the case: activated T-lymphocytes can readily cross the endothelial blood-brain barrier (BBB) and some glial cells, notably the astrocytes, seem to be programmed to act as most efficient and complex partners for antigen-specific T-lymphocytes. We used myelin basic protein (MBP) specific permanent rat T-lymphocyte lines as probes to assess the immune status of the CNS. These cells, upon activation in vitro, are able to transfer lethal, experimentally induced autoimmune-encephalomyelitis (EAE) to normal syngeneic recipients. Activated T-lymphocytes, but not resting ones, can break through the BBB irrespective of their antigen specificity. Immune surveillance of the CNS thus seems to be executed by activated T-lymphocytes. Having crossed the BBB, the activated T-cells interact with local glial cells by releasing factors, including interferon-gamma, which induced astrocytes to synthesize and express, on their membranes, class II major histocompatibility antigens (Ia determinants), which are critically required for immunogenic presentation of antigens to T-cells. Indeed, Ia-induced astrocytes of the CNS (and the Schwann cells of peripheral nerves) are efficient antigen presenter cells, which are able strongly to up-regulate antigen-reactive T-lymphocytes. In addition, it has recently been shown that at least some astrocytes are able to down-regulate immune cells. Some, but not all, astrocytes are capable of suppressing activation of T-cells. This suppression can be modulated by interferon-gamma, and is sensitive to irradiation. The question of whether suppression is mediated by direct cell-to-cell contact or via soluble mediators (e.g. apolipoprotein E) is under investigation. Astrocytes have been found to be most subtle regulators of immuno-competent T-cells. Most probably they are centrally involved in physiological immune reactivity of the CNS, and it will be tempting to learn how far glial cells are involved in transmitting regulatory signals between the immune and nervous systems.

Entities:  

Mesh:

Year:  1987        PMID: 3323405     DOI: 10.1242/jeb.132.1.43

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  38 in total

Review 1.  Retinal pigment epithelium differentiation of stem cells: current status and challenges.

Authors:  Basak E Uygun; Nripen Sharma; Martin Yarmush
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 2.  Major histocompatibility complex molecules on parenchymal cells of the target organ protect against autoimmune disease.

Authors:  Hui Shao; Henry J Kaplan; Deming Sun
Journal:  Chem Immunol Allergy       Date:  2007

Review 3.  Science gone translational: the OX40 agonist story.

Authors:  Andrew D Weinberg; Nicholas P Morris; Magdalena Kovacsovics-Bankowski; Walter J Urba; Brendan D Curti
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

4.  Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.

Authors:  J B Guerreiro; S B Santos; D J Morgan; A F Porto; A L Muniz; J L Ho; A L Teixeira; M M Teixeira; E M Carvalho
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 5.  Immune control of the brain.

Authors:  M Bradl
Journal:  Springer Semin Immunopathol       Date:  1996

6.  Adenovirus-mediated gene transfer of B7.1 induces immunological anti-tumor effects in a murine brain tumor.

Authors:  Jun Morioka; Koji Kajiwara; Koichi Yoshikawa; Makoto Ideguchi; Tetsuya Uchida; Yoshinori Ohmoto; Michiyasu Suzuki
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

7.  Role of the MHC2TA gene in autoimmune diseases.

Authors:  Alfonso Martínez; Marta Sánchez-Lopez; Jezabel Varadé; Ana Mas; M Carmen Martín; Virginia de Las Heras; Rafael Arroyo; Juan Luis Mendoza; Manuel Díaz-Rubio; Benjamín Fernández-Gutiérrez; Emilio G de la Concha; Elena Urcelay
Journal:  Ann Rheum Dis       Date:  2006-09-29       Impact factor: 19.103

Review 8.  CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

Authors:  Nancy Bartolotti; Orly Lazarov
Journal:  Brain Behav Immun       Date:  2019-01-12       Impact factor: 7.217

9.  MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity.

Authors:  Magali Irla; Natalia Küpfer; Tobias Suter; Rami Lissilaa; Mahdia Benkhoucha; Jonathan Skupsky; Patrice H Lalive; Adriano Fontana; Walter Reith; Stéphanie Hugues
Journal:  J Exp Med       Date:  2010-08-09       Impact factor: 14.307

Review 10.  Clinical applications of a peptide-based vaccine for glioblastoma.

Authors:  Charles W Kanaly; Dale Ding; Amy B Heimberger; John H Sampson
Journal:  Neurosurg Clin N Am       Date:  2010-01       Impact factor: 2.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.